Literature DB >> 24189823

[Chylothorax in a patient with advanced gastric cancer and mediastinal lymph node metastasis causing thoracic duct obstruction].

Kazuya Yoshizawa1, Yu Sasaki, Yasuhiko Abe, Nana Kanno, Naoko Mizumoto, Makoto Yagi, Takao Yaoita, Daisuke Iwano, Ko Nagino, Takeshi Sato, Eiki Nomura, Shoichi Nishise, Yoshiyuki Ueno.   

Abstract

We report the case of a 61-year-old female with advanced gastric cancer and mediastinal lymph node metastasis who developed chylothorax. The patient presented with cough, dyspnea and pain in the left lower limb, back, and hips. Her lower limb symptoms were attributed to cellulitis. Computed tomography revealed right-sided pleural effusion, multiple lymph node swelling, and thickening of the gastric wall. Following pleural aspiration, the effusion was identified to be chyle. Cytopathologically, numerous adenocarcinoma cells were detected in clumps, and subsequent esophagogastroduodenoscopy revealed type 3 gastric cancer. We diagnosed multiple lymph node metastases with pleural dissemination. Chemotherapy was administered; however, she eventually succumbed to disease progression. We suspected that the chylothorax resulted from the mediastinal lymph node metastasis that caused thoracic duct obstruction.

Entities:  

Mesh:

Year:  2013        PMID: 24189823

Source DB:  PubMed          Journal:  Nihon Shokakibyo Gakkai Zasshi        ISSN: 0446-6586


  2 in total

1.  Chylothorax and lymphedema as the initial manifestations of gastric carcinoma: A case report and review of the literature.

Authors:  Jie Wu; Liang Lv; Kunyan Zhou; Jirong Huo
Journal:  Oncol Lett       Date:  2016-02-29       Impact factor: 2.967

Review 2.  Refractory Chylothorax and Lymphedema Caused by Advanced Gastric Cancer.

Authors:  Naoko Nagano; Manabu Suzuki; Kentaro Tamura; Sakurako Kobayashi; Yasushi Kojima; Go Naka; Motoyasu Iikura; Shinyu Izumi; Yuichiro Takeda; Haruhito Sugiyama
Journal:  Intern Med       Date:  2019-07-10       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.